Characteristics unique to PWS, such as food-seeking behaviors and high threshold for pain, likely contribute to the risk for SA
Glutathione reduces melanocytes which produce melanin
This removes financial pressure to increase doses faster than your body can comfortably tolerate
GLP-1 medications also carry some serious (but rare) warnings: Potential risk of thyroid C-cell tumors (observed in rodent studies, unclear relevance in humans) Risk of gallbladder problems Pancreatitis (rare but documented) Hair loss (temporary, related to rapid weight loss rather than the drug itself) One notable advantage of GLP-1 medications: they do not cause cognitive dysfunction, do not carry teratogenicity warnings as severe as topiramate, and are not controlled substances
Currently, there are five registered clinical trials to evaluate the effect of semaglutide in AUD, and some are already recruiting 28,29,30,31,32